Novartis Inc header image

Novartis Inc

NOVN

Equity

ISIN CH0012005267 / Valor 1200526

SIX Swiss Exchange (2026-10-23)
CHF 128.00-0.68%

Novartis Inc
UMushroom community rating:

star star star star star
4.06 50 votes No rating yet
NegativeNeutralPositive

About company

Novartis Inc. is a global healthcare company that specializes in the development and distribution of innovative medicines. With a focus on addressing unmet medical needs, Novartis aims to improve and extend the lives of people suffering from serious diseases. The company operates in several core therapeutic areas, including cardiovascular, renal and metabolic diseases, immunology, neuroscience, and oncology. Novartis is known for its commitment to research and development, leveraging advanced technology platforms to create groundbreaking therapies. With a workforce of approximately 78,000 employees representing over 140 nationalities, Novartis has a significant global presence, reaching more than 284 million patients worldwide. The company's strategy revolves around delivering high-value medicines and employing novel access approaches to alleviate some of society's most significant disease burdens.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

22.5%1Y
51.5%3Y
74.2%5Y

Performance

23.7%1Y
20.7%3Y
19.6%5Y

Volatility

Market cap

294871 M

Market cap (USD)

Daily traded volume (Shares)

2,831,710

Daily traded volume (Shares)

1 day high/low

88.82 / 87.81

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.06

50 votes
Performance:
starstarstarstarstar
3.68
Innovation:
starstarstarstarstar
3.89
Society:
starstarstarstarstar
3.76
Nature:
starstarstarstarstar
3.33
Julian Hangartner
Switzerland, 21 Oct 2026
star star star star star
Das ist eine sehr gute Aktie wenn man langfristig investieren möchte.
Denys Vodniev
Netherlands, 16 Oct 2026
star star star star star
.
Simao Sousa
Switzerland, 16 Oct 2026
star star star star star
Swiss Pharma, great for diversification and hedging.

EQUITIES OF THE SAME SECTOR

Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals Inc Syndax Pharmaceuticals Inc Valor: 24112479
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.25%USD 13.40
Medartis Holding AG
Medartis Holding AG Medartis Holding AG Valor: 38620023
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.73%CHF 94.20
BioArctic AB
BioArctic AB BioArctic AB Valor: 38514501
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.46%SEK 300.00
CorVel Corp
CorVel Corp CorVel Corp Valor: 921843
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.01%USD 83.87
Insmed Inc
Insmed Inc Insmed Inc Valor: 12614415
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.76%USD 93.39
Harmony Biosciences Holdings Inc
Harmony Biosciences Holdings Inc Harmony Biosciences Holdings Inc Valor: 56295735
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.28%USD 36.13
Helen of Troy Ltd
Helen of Troy Ltd Helen of Troy Ltd Valor: 938381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.07%USD 28.07
Galapagos NV
Galapagos NV Galapagos NV Valor: 2130343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.88%EUR 28.14
Inventiva SA
Inventiva SA Inventiva SA Valor: 35598121
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.45%EUR 3.06
Merck KGaA
Merck KGaA Merck KGaA Valor: 412799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.08%EUR 143.30